Market Overview:
The global osteoporosis treatment market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to factors such as rising incidence of osteoporosis, increasing awareness about available treatments, and growing demand for better and more effective therapies. Based on type, the global osteoporosis treatment market is segmented into bisphosphonates, parathyroid hormone therapy (PTH), calcitonin, and selective estrogen inhibitors modulator (SERM). Bisphosphonates are the most commonly used drugs for treating osteoporosis and are expected to dominate the market during the forecast period. However, PTH therapy is gaining popularity due to its ability to improve bone density and reduce fracture risk in postmenopausal women with low bone mass or osteopenia. Based on application, hospitals accounted for the largest share of the global osteoporosis treatment market in 2017. This can be attributed to increasing number of hospital admissions owing to fractures caused by fragility fractures associated with advanced stages of this disease.
Product Definition:
Osteoporosis Treatment is a process or plan of action used to improve bone density and reduce the risk of fractures in people with osteoporosis.
Bisphosphonates:
Bisphosphonates are chemical compounds that are used to treat osteoporosis. Osteoporosis is a disease characterized by weak bones caused due to low bone density. The normal range for the human bone mineral density should be 2.5 - 3.4 g/cm3, however, in case of women over 50 years of age this value reduces to 1.7-2 g/cm3 leading to weak bones and increased risk of fractures (breakage).
Parathyroid Hormone Therapy:
Parathyroid hormone (PTH) is a peptide hormone that regulates the release of calcium from the bones in response to changes in body temperature. PTH, when administered intravenously, increases bone mineral density and reduces bone turnover. Osteoporosis causes reduction in height and weight of bones due to weak connective tissue which makes them more likely to fracture.
Application Insights:
Based on application, the global osteoporosis treatment market is segmented into hospitals, clinics and other medical facilities. Hospitals held the largest share in 2017 owing to factors such as high patient admissions due to chronic diseases such as cancer and diabetes. In addition, hospitals are engaged in providing better treatment options leading to increased demand for these drugs at a hospital level.
Clinic applications are expected to witness significant growth over the forecast period due to increasing awareness about bone health among geriatric groups and women population of reproductive age group. Furthermore, rising incidences of hip fractures caused by low bone mass among elderly people will boost product demand over the forecast period. Osteoporosis causes severe pain in bones which cannot be treated with medication so patients prefer going for treatments that provide instant relief from this condition which is boosting market growth at present moment.
Regional Analysis:
North America dominated the global osteoporosis treatment market in 2017. This can be attributed to the high prevalence of osteoporosis-related fractures, increasing R&D investments by companies, and rising awareness about osteoporosis diagnosis & treatment. Moreover, a higher per capita healthcare expenditure and availability of reimbursement facilities are some other factors contributing toward its growth. The U.S.
Asia Pacific region is expected witness lucrative growth over the forecast period owing to improving economic conditions.
Growth Factors:
- Increasing geriatric population: The global geriatric population is increasing at a rapid pace. This is expected to drive the demand for osteoporosis treatment products in the coming years.
- Growing awareness about osteoporosis: There is a growing awareness about osteoporosis among people across the world. This is likely to boost the demand for osteoporosis treatment products in the near future.
- Rising incidence of fractures: The incidence of fractures due to osteoporosis is on the rise globally, which is expected to fuel demand for effective treatments for this condition in the coming years.
- Technological advancements: There has been significant progress in technology with respect to diagnosis and treatment of osteoporosis in recent years, which is likely to propel market growth over the forecast period . 5) Availability of reimbursement policies: A number of countries have introduced reimbursement policies for drugs used in treating osteoporosis, which will help increase their adoption and drive market growth
Scope Of The Report
Report Attributes
Report Details
Report Title
Osteoporosis Treatment Market Research Report
By Type
Bisphosphonates, Parathyroid Hormone Therapy, Calcitonin, Selective Estrogen Inhibitors Modulator (SERM)
By Application
Hospitals, Clinic, Others
By Companies
Allergan Plc, Amgen, Inc., Actavis Plc., Eli Lilly and Company, F. Hoffmann La Roche Ltd., GlaxoSmithKline Pharmaceutical Ltd., Merck & Co AG, Novartis AG, Novo Nordisk A/S, Pfizer, Inc., Teva Pharmaceuticals Industries Ltd.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
169
Number of Tables & Figures
119
Customization Available
Yes, the report can be customized as per your need.
Global Osteoporosis Treatment Market Report Segments:
The global Osteoporosis Treatment market is segmented on the basis of:
Types
Bisphosphonates, Parathyroid Hormone Therapy, Calcitonin, Selective Estrogen Inhibitors Modulator (SERM)
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinic, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Allergan Plc
- Amgen, Inc.
- Actavis Plc.
- Eli Lilly and Company
- F. Hoffmann La Roche Ltd.
- GlaxoSmithKline Pharmaceutical Ltd.
- Merck & Co AG
- Novartis AG
- Novo Nordisk A/S
- Pfizer, Inc.
- Teva Pharmaceuticals Industries Ltd.
Highlights of The Osteoporosis Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Bisphosphonates
- Parathyroid Hormone Therapy
- Calcitonin
- Selective Estrogen Inhibitors Modulator (SERM)
- By Application:
- Hospitals
- Clinic
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Osteoporosis Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Osteoporosis is a disease that causes bones to become thin and brittle. Treatment for osteoporosis includes medications, surgery, and physical therapy.
Some of the major companies in the osteoporosis treatment market are Allergan Plc, Amgen, Inc., Actavis Plc., Eli Lilly and Company, F. Hoffmann La Roche Ltd., GlaxoSmithKline Pharmaceutical Ltd., Merck & Co AG, Novartis AG, Novo Nordisk A/S, Pfizer, Inc., Teva Pharmaceuticals Industries Ltd..
The osteoporosis treatment market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Osteoporosis Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Osteoporosis Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Osteoporosis Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Osteoporosis Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Osteoporosis Treatment Market Size & Forecast, 2018-2028
4.5.1 Osteoporosis Treatment Market Size and Y-o-Y Growth
4.5.2 Osteoporosis Treatment Market Absolute $ Opportunity
Chapter 5 Global Osteoporosis Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Osteoporosis Treatment Market Size Forecast by Type
5.2.1 Bisphosphonates
5.2.2 Parathyroid Hormone Therapy
5.2.3 Calcitonin
5.2.4 Selective Estrogen Inhibitors Modulator (SERM)
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Osteoporosis Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Osteoporosis Treatment Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinic
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Osteoporosis Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Osteoporosis Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Osteoporosis Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Osteoporosis Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Osteoporosis Treatment Market Size Forecast by Type
9.6.1 Bisphosphonates
9.6.2 Parathyroid Hormone Therapy
9.6.3 Calcitonin
9.6.4 Selective Estrogen Inhibitors Modulator (SERM)
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Osteoporosis Treatment Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinic
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Osteoporosis Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Osteoporosis Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Osteoporosis Treatment Market Size Forecast by Type
10.6.1 Bisphosphonates
10.6.2 Parathyroid Hormone Therapy
10.6.3 Calcitonin
10.6.4 Selective Estrogen Inhibitors Modulator (SERM)
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Osteoporosis Treatment Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinic
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Osteoporosis Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Osteoporosis Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Osteoporosis Treatment Market Size Forecast by Type
11.6.1 Bisphosphonates
11.6.2 Parathyroid Hormone Therapy
11.6.3 Calcitonin
11.6.4 Selective Estrogen Inhibitors Modulator (SERM)
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Osteoporosis Treatment Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinic
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Osteoporosis Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Osteoporosis Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Osteoporosis Treatment Market Size Forecast by Type
12.6.1 Bisphosphonates
12.6.2 Parathyroid Hormone Therapy
12.6.3 Calcitonin
12.6.4 Selective Estrogen Inhibitors Modulator (SERM)
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Osteoporosis Treatment Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinic
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Osteoporosis Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Osteoporosis Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Osteoporosis Treatment Market Size Forecast by Type
13.6.1 Bisphosphonates
13.6.2 Parathyroid Hormone Therapy
13.6.3 Calcitonin
13.6.4 Selective Estrogen Inhibitors Modulator (SERM)
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Osteoporosis Treatment Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinic
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Osteoporosis Treatment Market: Competitive Dashboard
14.2 Global Osteoporosis Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Allergan Plc
14.3.2 Amgen, Inc.
14.3.3 Actavis Plc.
14.3.4 Eli Lilly and Company
14.3.5 F. Hoffmann La Roche Ltd.
14.3.6 GlaxoSmithKline Pharmaceutical Ltd.
14.3.7 Merck & Co AG
14.3.8 Novartis AG
14.3.9 Novo Nordisk A/S
14.3.10 Pfizer, Inc.
14.3.11 Teva Pharmaceuticals Industries Ltd.
